Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.77 is 55% above its 5-year average of 1.14, near the high end of its 5-year range (0.44–2.22).
As of the fiscal period ended Tuesday, June 30, 2026. 25.09% above its 12-month average of 1.41.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.77.
CURRENT RATIO
1.77
CURRENT RATIO AVG TTM
1.41
CURRENT RATIO AVG 3Y
0.73
CURRENT RATIO AVG 5Y
1.14
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+25.09%
CURRENT VS 3Y AVG
+141.73%
CURRENT VS 5Y AVG
+55.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 569 covered companies
CURRENT VS SECTOR MEDIAN
-47.21%
vs the sector median at left
Market Cap
$35.58M
Current Ratio
7.07
TTM Avg
2.75
3Y Avg
16.37
5Y Avg
28.22
Market Cap
$36.32M
Current Ratio
2.77
TTM Avg
2.09
3Y Avg
1.85
5Y Avg
2.65
Market Cap
$34.01M
Current Ratio
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
Market Cap
$38.90M
Current Ratio
1.87
TTM Avg
1.51
3Y Avg
1.77
5Y Avg
1.99
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $35.82M | 1.77 | 1.41 | 0.73 | 1.14 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.58M | 7.07 | 2.75 | 16.37 | 28.22 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | 2.77 | 2.09 | 1.85 | 2.65 |
| DocGo Inc. (DCGO)vs › | $36.38M | 1.66 | 2.38 | 2.37 | 2.73 |
| Accuray Incorporated (ARAY)vs › | $37.14M | 1.50 | 1.57 | 1.63 | 1.67 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.01M | 11.47 | 9.93 | 10.68 | 16.03 |
| Edesa Biotech, Inc. (EDSA)vs › | $37.81M | 2.76 | 5.79 | 4.84 | 5.49 |
| HeartBeam, Inc. (BEAT)vs › | $33.31M | 3.66 | 1.58 | 4.92 | 7.25 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.90M | 1.87 | 1.51 | 1.77 | 1.99 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.92M | 2.19 | 3.38 | 4.17 | 5.03 |
Current Ratio
1.77
Quick Ratio
1.64
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.77 |
| 2026-03-31 | 2.05 |
| 2025-12-31 | 2.22 |
| 2025-09-30 | 0.44 |
| 2025-06-30 | 0.59 |
| 2025-03-31 | 0.81 |
| 2024-12-31 | 0.69 |
| 2024-09-30 | 0.94 |
| 2024-06-30 | 0.76 |
| 2024-03-31 | 0.63 |
| 2023-12-31 | 0.73 |
| 2023-09-30 | 0.87 |
| 2023-06-30 | 0.84 |
| 2023-03-31 | 1.05 |
| 2022-12-31 | 1.19 |
| 2022-09-30 | 1.09 |
| 2022-06-30 | 1.00 |
| 2022-03-31 | 1.50 |
| 2021-12-31 | 1.82 |
| 2021-09-30 | 1.74 |
